NCT06275815 Promoting Caregiver Implementation of an Effective Early Learning Intervention
| NCT ID | NCT06275815 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ohio State University |
| Condition | Developmental Language Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 320 participants |
| Start Date | 2024-04-10 |
| Primary Completion | 2028-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 320 participants in total. It began in 2024-04-10 with a primary completion date of 2028-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to examine the impact of a caregiver-implemented shared reading program, Sit Together and Read (STAR), on children ages 4 to 5 with developmental language disorder. The main questions it aims to answer are: * how much STAR impacts children's literacy skills in the short-term and long-term--up to two-years after completing STAR. * how do caregiver supports in the form of small monetary rewards or encouraging texts help caregivers to implement STAR at its intended frequency of sessions per week. Caregiver participants will be assigned to either a control group or one of three STAR groups. Children's skills related to literacy and learning will be assessed before the intervention starts, at the end of the intervention, and every six months post-intervention for two years. Researchers will determine the short term and long term impacts of STAR compared to the control group. Researchers will compare the three STAR conditions to see if the rewards or encouragement helped parents to follow through with completing more STAR sessions.
Eligibility Criteria
Inclusion Criteria: * receiving or on waitlist for speech services * primary complaint of impaired language skills * receptive, expressive, or mixed language disorder * primarily communicates in English Exclusion Criteria: 1. No known additional diagnoses causal of developmental language disorder including 1. autism spectrum disorder 2. hearing loss 3. severe intellectual disability 2. Is not attending or has completed Kindergarten
Contact & Investigator
Laura M Justice, PhD
PRINCIPAL INVESTIGATOR
Ohio State University
Frequently Asked Questions
Who can join the NCT06275815 clinical trial?
This trial is open to participants of all sexes, aged 48 Months or older, up to 71 Months, studying Developmental Language Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06275815 currently recruiting?
Yes, NCT06275815 is actively recruiting participants. Contact the research team at bostic.18@osu.edu for enrollment information.
Where is the NCT06275815 trial being conducted?
This trial is being conducted at Columbus, United States, Columbus, United States.
Who is sponsoring the NCT06275815 clinical trial?
NCT06275815 is sponsored by Ohio State University. The principal investigator is Laura M Justice, PhD at Ohio State University. The trial plans to enroll 320 participants.